Among those who have been obese or overweight in past five years, 34% have used the medications and 23% are currently
Some patients also experience increased blood pressure shortly after administration, which is why its not recommended for individuals with uncontrolled hypertension
The money-back guarantee and cancel-anytime terms mean trying it is low-risk: if the program does not fit, you are not locked in
ATTR amyloidosis can be further categorized into hereditary/variant (ATTRv) or wildtype (ATTRwt) form
Most-engaged members lost 25.2% more weight at week 40 and persisted 2.2x longer on medication program than least-engaged members using the Noom app, demonstrating the benefits of combining GLP-1 medication with Nooms GLP-1 Companion behavior-change program PRINCETON, N.J., February 4, 2026 Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Nooms leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer
doi: 10.3892/mmr.2025.13574 163 SimpsonAPetngaWMacaulayVMWeyer-CzernilofskyUBogenriederT
